Skip to main content

Day: December 28, 2020

Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, today announces the appointment of Bret Scholtes, a veteran of the nutritional products industry for nearly a decade, as its President and Chief Executive Officer, and as a member of the Board of Directors, commencing January 6, 2021.“We are delighted to welcome Bret to Guardion Health Sciences. We believe that his proven business acumen and extensive experience in the nutritional products industry will serve to usher Guardion into a new era of growth and success,” commented Robert Weingarten, Chairman of the Board of Guardion Health Sciences. “Bret’s...

Continue reading

ARMOUR Residential REIT, Inc. Announces Guidance for January 2021 Dividend Rate per Common Share

VERO BEACH, Florida, Dec. 28, 2020 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the January 2021 cash dividend for the Company’s Common Stock, which maintains the current monthly dividend rate of $0.10 per Common share.January 2021 Common Stock Dividend InformationCertain Tax MattersARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined at the discretion of the Company’s board of directors, which...

Continue reading

UFP Industries, Inc. closes on purchase of PalletOne, bolstering its position as the nation’s preferred supplier of industrial packaging and pressure-treated lumber

GRAND RAPIDS, Mich., Dec. 28, 2020 (GLOBE NEWSWIRE) — UFP Industries, Inc. (Nasdaq: UFPI) today announced that UFP Industrial, LLC, closed on its agreement to purchase 100 percent of the equity of PalletOne, Inc. for approximately $232 million. This price assumes a cash-free, debt-free balance sheet and an agreement to pay $21 million for PalletOne’s recent capital expenditures and other investments. The PalletOne management team, including President Howe Wallace, will continue to lead the company.Scott Worthington, president of UFP Industrial, commented, “We are excited to welcome the PalletOne team to the UFP family of companies and look forward to executing PalletOne’s strategy while realizing the operating benefits and synergies of our respective organizations.”UFP Industries, Inc.UFP Industries is a holding company whose operating...

Continue reading

Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

FLORHAM PARK, N.J., Dec. 28, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously announced underwritten public offering of its common stock for gross proceeds of approximately $24.5 million at a public offering price of $1.35 per share of common stock, prior to deducting underwriting discounts and commissions and estimated offering expenses.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, Cellectar offered and sold 1,518.5180 shares of Series D convertible preferred stock convertible into a number of shares of common stock equal to $13,500 divided by $1.35 (or 10,000 shares...

Continue reading

Rezolute Announces Change of Transfer Agent

REDWOOD CITY, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq:RZLT), focused on advancing therapies for rare, metabolic and life-threatening diseases, announced today the appointment of IssuerDirect as the Company’s registrar and transfer agent and shareholder support provider. IssuerDirect will now be responsible for all transfers of Rezolute shares rather than VStock Transfer, LLC. Shareholders need take no action related to this transaction.About Rezolute, Inc.Rezolute is advancing targeted therapies for rare, metabolic, and life-threatening diseases. Its lead clinical asset, RZ358, is in Phase 2b development as a potential treatment for congenital HI, a rare pediatric endocrine disorder. Its pipeline also includes RZ402, an IND-ready orally available plasma kallikrein inhibitor which is staged to transition into...

Continue reading

Digirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.

Name Change Effective as of January 1, 2021 No Change to Names of Customer-Facing BusinessesSUWANEE, Ga., Dec. 28, 2020 (GLOBE NEWSWIRE) — Digirad Corporation (Nasdaq: DRAD; DRADP) (the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, announced today that it has changed its corporate name to Star Equity Holdings, Inc. (“Star Equity Holdings”) with an effective date of January 1, 2021 (“Effective Date”). The website for Star Equity Holdings will be www.starequity.com. In connection with the corporate name change, the Company’s Common Stock will begin trading under the new ticker symbol “STRR” and have a CUSIP of 85513Q103, and the Company’s Series A Cumulative Perpetual Preferred Stock will begin trading under the new ticker symbol “STRRP”...

Continue reading

Epsilon Reports Plan to Repurchase Shares Pursuant to a Normal Course Issuer Bid

HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that the Board of Directors has authorized the repurchase of up to 1,193,000 of the outstanding common shares, representing 5% of the outstanding common shares of Epsilon, pursuant to a normal course issuer bid, during the one-year period commencing on January 1st, 2021. The program will end on December 31st, 2021 unless the maximum amount of common shares is purchased before then or Epsilon provides earlier notice of termination.Repurchases may be made at management’s discretion from time to time through the facilities of the NASDAQ Global Market. The price paid for the common shares will be, subject to applicable securities laws, the prevailing market price of such common shares on the NASDAQ Global Market...

Continue reading

CleanSpark to Discuss Bitcoin Mining Acquisition and Related Growth Opportunities

SALT LAKE CITY, Dec. 28, 2020 (GLOBE NEWSWIRE) — SALT LAKE CITY, December 28, 2020 — CleanSpark, Inc. (Nasdaq: CLSK), (“CleanSpark, or the Company”), an advanced software and controls technology solutions company focused on solving modern energy challenges, will be participating in the Water Tower Research Fireside Chat Series on Tuesday, December 29, 2020, at 3:00 pm ET. Topics covered will include insight into the company’s Bitcoin mining operation and newly-revised 2021 guidance including the ATL Data Center acquisition.The chat will feature Zachary Bradford, CleanSpark’s Chief Executive Officer. The host and moderator will be Shawn Severson, Head of Sustainable Investing at Water Tower Research. A brief question and answer session focusing on the Company’s year-end 2020 filing will follow.Investors interested in participating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.